Skip to content
Screener

Baxter International BAX Financing Cash Flow

Financing Cash Flow at other companies

Stryker logo
StrykerSYK
-$95M
KORU Medical Systems logo
KORU Medical SystemsKRMD
-$118.82K+38.1%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
-$75.8M-781%
Axogen logo
AxogenAXGN
$4.2M+263%
ICU Medical logo
ICU MedicalICUI
-$50.24M+74.2%
Omnicell logo
OmnicellOMCL
-$23.38M-104%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$14.13B+22.3%
Enterprise value$12.33B+22.1%
P/S1.3×+0.2×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The source filing: Baxter International’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:50 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028962
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Cash dividends on common stock(5)(87)
Proceeds from stock issued under employee benefit plans810
Other financing activities, net(14)(24)
Cash flows from (used in) financing activities(11)(3,226)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash - continuing operations(18)36
Increase (decrease) in cash, cash equivalents and restricted cash51(118)
Cash, cash equivalents and restricted cash at beginning of period (1)1,9682,414
Cash, cash equivalents and restricted cash at end of period (1)2,0192,296

Item 1. Financial Statements (unaudited)

FAQ

What is Baxter International's financing cash flow?
Baxter International (BAX) reported financing cash flow of -$11M in Q1 2026.
How has Baxter International's financing cash flow changed year-over-year?
Baxter International's financing cash flow increased by 99.7% year-over-year, from -$3.23B to -$11M.
What is the long-term trend for Baxter International's financing cash flow?
Over 3 years (2021 to 2025), Baxter International's financing cash flow has grown at a -20.0% compound annual growth rate (CAGR), from $8.25B to -$4.22B.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Ask your AI about Baxter International's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude